|
| 山莨菪碱联合低分子肝素对肺心病患者血液流变学观察 |
| Effect of Anisodarnine Combined Low-melecular-weight Heparins (LMWHs) in the Treatment of Chronic Pulmonary Heart Diseases |
| |
| DOI： |
| 中文关键词: 山莨菪碱 低分子肝素 肺心病 血液流变学 联合用药 急性加重期 |
| 英文关键词:Low-molecular-weight Heparins (LMWHs),Chronic pulmonary heart diseases,Hemorrheology,Anisodarnine |
| 基金项目: |
| 田廷娅 |
| 武汉市第四医院呼吸内科 武汉430033 |
| 摘要点击次数: 1715 |
| 全文下载次数: 93 |
| 中文摘要: |
| 目的：探讨山莨菪碱联合低分子肝素对肺心病患者血液流变学的影响。方法：60例均符合肺心病诊断标准，经随机、双盲分组，对照组30例给予常规吸氧、抗感染、平喘药治疗2周；实验组30例在常规治弃基础上加用山莨菪碱联合低分子肝素治疗。结果：实验组治疗前后血液流变学变化显著，无明显不良反应。结论：山莨菪碱联合低分子肝素治疗肺心病患者安全有效，无明显不良反应。 |
| 英文摘要: |
| Objective: To study the effect of anisodarnine combined LMWHs on hemorrheology of chronic pulmonary heart diseases. Methods: 60 patients with chronic pulmonary heart diseases were randomly divided into 2 groups, and 30 patients in the therapy group were treated with anisodarnine combined LMWHs. All the patients in both groups were observed before and after the treatment. Result: Hemorrheology was markedly changed in the therapy group after the treatment with anisodarnine combined LMWHs. Conclusion: Anisodarnine combined LMWHs treatment of the chronic pulmonary heart diseases is efficacious and safe. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
